Overview

Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The aim of the exploratory study is to compare dose related effects of LAS41004 formulations in a non-occlusive PPT.
Phase:
Phase 2
Details
Lead Sponsor:
Almirall, S.A.
Collaborator:
proDERM GmbH